Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-18 4:38 pm Purchase | 2026-02-11 | 13G | Supernus Pharmaceuticals, Inc. SUPN | Millennium Management LLC | 3,281,615 5.700% | 245,492 (+8.09%) | Filing History |
| 2026-02-17 9:37 pm Sale | 2025-12-31 | 13G | Supernus Pharmaceuticals, Inc. SUPN | Armistice Capital, LLC | 2,764,000 4.820% | -72,000 (-2.54%) | Filing History |
| 2026-02-02 4:33 pm Purchase | 2026-01-26 | 13G | Supernus Pharmaceuticals, Inc. SUPN | Millennium Management LLC | 3,036,123 5.300% | 3,036,123 (New Position) | Filing History |
| 2026-01-21 1:21 pm Sale | 2025-12-31 | 13G | Supernus Pharmaceuticals, Inc. SUPN | DIMENSIONAL FUND ADVISORS LP | 2,712,341 4.700% | -170,164 (-5.90%) | Filing History |
| 2025-11-14 6:27 pm Sale | 2025-09-30 | 13G | Supernus Pharmaceuticals, Inc. SUPN | Armistice Capital, LLC | 2,836,000 5.060% | -2,360,000 (-45.42%) | Filing History |
| 2025-08-15 12:28 pm Purchase | 2025-06-30 | 13G | ProMIS Neurosciences, Inc. PMN | Armistice Capital, LLC | 192,480 8.580% | 192,480 (New Position) | Filing History |
| 2025-05-15 3:18 pm Purchase | 2025-03-31 | 13G | Supernus Pharmaceuticals, Inc. SUPN | Armistice Capital, LLC | 5,196,000 9.280% | 360,000 (+7.44%) | Filing History |
| 2025-04-22 08:27 am Sale | 2025-03-31 | 13G | Supernus Pharmaceuticals, Inc. SUPN | BlackRock Inc. BLK | 8,197,023 14.700% | -2,184,295 (-21.04%) | Filing History |
| 2025-02-14 5:20 pm Sale | 2024-12-31 | 13G | Supernus Pharmaceuticals, Inc. SUPN | Armistice Capital, LLC | 4,836,000 8.760% | -260,000 (-5.10%) | Filing History |
| 2024-11-14 5:14 pm Purchase | 2024-09-30 | 13G | Supernus Pharmaceuticals, Inc. SUPN | Armistice Capital, LLC | 5,096,000 9.250% | 446,000 (+9.59%) | Filing History |
| 2024-11-01 4:35 pm Sale | 2024-09-30 | 13G | Supernus Pharmaceuticals, Inc. SUPN | Macquarie Group Limited | 2,631,897 4.780% | -105,824 (-3.87%) | Filing History |
| 2024-10-31 11:55 am Purchase | 2024-10-31 | 13G | Supernus Pharmaceuticals, Inc. SUPN | DIMENSIONAL FUND ADVISORS LP | 2,882,505 5.200% | 2,882,505 (New Position) | Filing History |
| 2024-02-14 2:33 pm Purchase | 2023-12-31 | 13G | Supernus Pharmaceuticals, Inc. SUPN | Armistice Capital, LLC | 4,650,000 8.510% | 294,000 (+6.75%) | Filing History |
| 2024-02-14 07:06 am Purchase | 2023-12-31 | 13G | Supernus Pharmaceuticals, Inc. SUPN | Macquarie Group Limited | 2,737,721 5.010% | 2,737,721 (New Position) | Filing History |
| 2024-02-13 5:15 pm Purchase | 2023-12-29 | 13G | Supernus Pharmaceuticals, Inc. SUPN | The Vanguard Group | 6,214,731 11.380% | 424,771 (+7.34%) | Filing History |
| 2024-01-19 2:40 pm Purchase | 2023-12-31 | 13G | Supernus Pharmaceuticals, Inc. SUPN | BlackRock Inc. BLK | 10,381,318 19.000% | 777,245 (+8.09%) | Filing History |
| 2023-02-14 1:33 pm Purchase | 2022-12-31 | 13G | Supernus Pharmaceuticals, Inc. SUPN | Armistice Capital, LLC | 4,356,000 8.060% | 220,000 (+5.32%) | Filing History |
| 2023-02-09 11:32 am Purchase | 2022-12-30 | 13G | Supernus Pharmaceuticals, Inc. SUPN | The Vanguard Group | 5,789,960 10.710% | 276,811 (+5.02%) | Filing History |
| 2023-01-23 3:52 pm Purchase | 2022-12-31 | 13G | Supernus Pharmaceuticals, Inc. SUPN | BlackRock Inc. BLK | 9,604,073 17.800% | 1,153,051 (+13.64%) | Filing History |
| 2022-02-14 7:03 pm Purchase | 2021-12-31 | 13G | Supernus Pharmaceuticals, Inc. SUPN | Armistice Capital, LLC | 4,136,000 7.800% | 1,016,000 (+32.56%) | Filing History |